logo
Share SHARE
FONT-SIZE Plus   Neg

Coronado Biosciences Prices Public Offering Of 5 Mln Shares At $5.00/shr

Coronado Biosciences Inc. (CNDO) announced the pricing of its underwritten public offering of 5 million shares of its common stock at a price to the public of $5.00 per share for gross proceeds to Coronado of $25.0 million.

Coronado said it expects to receive approximately $23.0 million in net proceeds from the offering, after deducting underwriting discount and estimated offering expenses.

The company also has granted the underwriters a 30-day option to purchase up to an aggregate of 750,000 additional shares of common stock to cover over-allotments, if any. The offering is expected to close on June 27, 2012, subject to customary closing conditions.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Alteryx, Inc., a provider of self-service data analytics software, is the latest tech company to go public in March. Alteryx said it has priced its IPO of 9 million shares of its Class A common stock at $14 per share, at the top end of its range of $12 to $14 per share. Dunkin' Donuts is bidding adieu to one of its frozen coffee beverages this summer. However, loyal fans of the decades-old menu staple have not taken kindly to the news. The coffee chain said it will discontinue its popular Coffee Coolatta beverage this summer and instead, introduce the new Frozen Dunkin' Coffee, made with coffee extract, sugar and milk. Canadian pipeline operator Enbridge Inc. said it will cut about 1,000 jobs, or six percent of its workforce, following the completion of its acquisition of Houston-based Spectra Energy Corp. The job cuts will take place across the merged company.
comments powered by Disqus
Follow RTT